A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers

Cancer

Volumn 82, Issue 9, 1998, Pages 1632-1637

  Vasen, Hans F A ^a,b   Van Ballegooijen, Marjolein ^c   Buskens, Eric ^d   Kleibeuker, Jan K ^e   Taal, Babs G ^f   Griffioen, Gerrit ^b   Nagengast, Fokko M ^g   Menko, Fred H ^h   Khan, P Meera ⁱ  

^a Netherlands Found Detection H   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Cost effectiveness; Gene carriers; Hereditary nonpolyposis colorectal carcinoma; Surveillance

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; FAMILIAL CANCER; HETEROZYGOTE DETECTION; HUMAN; PRIORITY JOURNAL;

ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COST-BENEFIT ANALYSIS; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED;

EID: 0032080634     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980501)82:9<1632::AID-CNCR6>3.0.CO;2-C     Document Type: Article

References (19)

1. Papadopoulos N, Nicolaides NC, Wei Y-S, Ruben SM, Carter KC, Haseltine WA, et al. Mutation of a MutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
2. Leach FS, Nicolaides NC, Papadopoulos N, Liu S, Jen J, Parsons R, et al. Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer. Cell 1993;75:1215-25.
3. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colorectal cancer. Cell 1993;75:1027-38.
4. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colorectal cancer. Nature 1994;368:258-61.
5. Wijnen J, Vasen H, Meera Khan P, Menko FH, van der Klift H, van Leeuwen C, et al. Seven new mutations in hMSH2 and HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 1995;56:1060-6.
6. Wijnen J, Khan PM, Vasen H, Menko FH, van der Klift H, van den Broek M, et al. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Human Genet 1996;58:300-7.
7. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
8. Mecklin J-P, Svendsen LB, Peltomaki P, Vasen HFA. Review: hereditary nonpolyposis colorectal cancer. Scand J Gastroenterol 1994;29:673-7.
9. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535-49.
10. Vasen HFA, Wijnen J, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
11. Vasen HFA, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH, et al. Hereditary nonpolyposis colorectal cancer: results of long-term-surveillance in 50 families. Eur J Cancer 1995;31A:1145-8.
12. Sankila R, Aaltonen LA, Järvinen HJ, Mecklin J-P. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-7.
13. Järvinen HJ, Mecklin J-P, Sistonen P. Screening reduces colorectal cancer rate in hereditary nonpolyposis colorectal cancer (HNPCC) families. Gastroenterology 1995:108:1405-11.
14. Wagner JL, Tunis S, Brown M, Ching A, Almeida R. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rozen R, Levin B, editors. Prevention and early detection of colorectal cancer. London: W. B. Saunders, 1996:321-41.
15. Taplin SH, Barlow W, Urban N, Mandelson MT, Timlin DJ, Ichikawa L, et al. Stage, age, comorbidity and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995;87:417-26.
16. Vasen HFA, Nagengast FM, Meera Khan P. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 1995;345:1183-4.
17. Vasen HFA, Watson P, Mecklin J-P, Jass JR, Green JS, Nomizu T, et al. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. Anticancer Res 1994;14:1675-8.
18. Burke W, Petersen G, Lynch P, Botkin J, Dayl M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. JAMA 1997;277:915-9.
19. Brown ML, Kessler LG. Use of gene tests to detect hereditary predisposition to cancer: what do we know about cost effectiveness? Int J Cancer 1996;69:55-7.